Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Modified recombinant human C-type natriuretic peptide

EU orphan designation number: EU/3/12/1094   
Active ingredient: Modified recombinant human C-type natriuretic peptide
Indication: Treatment of achondroplasia
Sponsor: BioMarin Europe Ltd
164 Shaftesbury Avenue, London WC2H 8HL, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
28/01/2013 Centralised Orphan - Designation EMA/OD/149/12 (2013)483 of 24/01/2013